RecycLiCo Secures Construction Permits, Advancing Laboratory Toward Early 2026 Completion

Stock Information for Eastwood Bio-Medical Canada Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Eastwood Bio-Medical Canada Inc.

RecycLiCo Reminds Shareholders to Vote in Advance of Proxy Voting Deadline for the Upcoming Annual General Meeting and Announces Independent Proxy Advisory Firm, ISS, Recommends Shareholders vote FOR
RecycLiCo Adds Rob Chang to Proposed Board of Directors
RecycLiCo Retains Retiring Director Andris Kikauka as Consultant to Support Legacy Mining Asset Management
RecycLiCo Announces Filing and Mailing of Management Information Circular for 2025 Annual General Meeting
RecycLiCo to Engage Global Investors and Industry Leaders at Benchmark Week 2025
RecycLiCo Announces Interim CEO's Open Letter to Shareholders Highlighting Strategic Milestones & Path Forward
RecycLiCo Retains Rain City Industrial for Design and Construction of Innovation Lab
RecycLiCo's U.S. Subsidiary and Alaska Energy Metals Corporation Enter Memorandum of Understanding to Advance Goal of Creating Domestic Critical Metal Supply Chain

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.